1. Vague J.. La differenciation sexuelle, facteur determinant des formes de l'obesite. Presse Med 30:1947;339–340.
2. Reaven G.M.. Banting lecture 1988. Role of insulin resistance in human disease.
Diabetes 37:1988;1595–1607.
3. Alberti K.G., Zimmet P.Z.. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.
Diabet Med 15:1998;539–553.
4. Balkau B., Charles M.A.. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR).
Diabet Med 16:1999;442–443.
5. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults . Executive summary of the third report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).
JAMA 285:2001;2486–2489.
6. Alberti K.G., Zimmet P., Shaw J.; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome—a new worldwide definition.
Lancet 366:2005;1059–1062.
7. Li P.K., Kwan B.C., Szeto C.C., Ko G.T.. Metabolic syndrome in peritoneal dialysis patients.
NDT Plus 1:2008;206–214.
8. Eckel R.E., Grundy S.M., Zimmet P.Z.. The metabolic syndrome.
Lancet 365:2005;1415–1428.
9. Sutherland J.P., McKinnley B., Eckel R.H.. The metabolic syndrome and inflammation.
Metab Syndr Rel Disord 2:2004;82–104.
10. de Mattos A.M., Ovidio P.P., Jordão A.A., da Costa J.A., Chiarello P.G.. Association of body fat with inflammation in peritoneal dialysis.
Inflammation 36:2013;689–695.
11. doi:10.1371/journal.pone.0062722.
12. Lee M.J., Shin D.H., Kim S.J., Oh H.J., Yoo D.E., Kim J.K., Park J.T., Han S.H., Kang S.W., Choi K.H., Yoo T.H.. Visceral fat thickness is associated with carotid atherosclerosis in peritoneal dialysis patients.
Obesity 20:2012;1301–1307.
13. Choi S.J., Kim E.J., Park M.Y., Kin J.K., Hwang S.D.. Does body fat mass define survival in patients starting peritoneal dialysis?
Perit Dial Int 34:2014;376–382.
14. Asicioglu E., Kahveci A., Arikan H., Koc M., Tuglular S., Ozener C.I.. Waist circumference is associated with carotid intima media thickness in peritoneal dialysis patients.
Int Urol Nephrol 45:2013;1437–1443.
15. Szeto C.C., Kwan B.C., Chow K.M., Leung C.B., Cheng M.S., Law M.C., Li P.K.. Metabolic syndrome in peritoneal dialysis patients: choice of diagnostic criteria and prognostic implications.
Clin J Am Soc Nephrol 9:2014;779–787.
16. Dong J., Wang Q., Chen M.H., Zhao H.P., Zhu T.Y., Tian N., Wang M., Hao C.M., Ren Y.P., Wang H.Y.. Associations between serum-intact parathyroid hormone, serum 25-hydroxyvitamin D, oral vitamin D analogs and metabolic syndrome in peritoneal dialysis patients: a multi-center cross-sectional study.
Perit Dial Int 34:2014;447–455.
17. Liao C.T., Kao T.W., Chou Y.H., Wu M.S., Chen Y.M., Chuang H.F., Hung K.Y., Chu T.S., Wu K.D., Tsai T.J.. Associations of metabolic syndrome and its components with cardiovascular outcomes among non-diabetic patients undergoing maintenance peritoneal dialysis.
Nephrol Dial Transplant 26:2011;4047–4054.
18. Prasad N., Sinha A., Gupta A., Sharma R.K., Kaul A., Bhadauria D., Ranagswamy D.. Effect of metabolic syndrome on clinical outcomes of non-diabetic peritoneal dialysis patients in India.
Nephrology 18:2013;657–664.
19. Huang J.W., Yang C.Y., Wu H.Y., Liu K.L., Su C.T., Wu C.K., Lee J.K., Chiang C.K., Cheng H.T., Lien Y.C., Hung K.Y.. Metabolic syndrome and abdominal fat are associated with inflammation, but not with clinical outcomes, in peritoneal dialysis patients.
Cardiovasc Diabetol 12:2013;86
20. WHO/International Association for the Study of Obesity International Obesity Task force. The Asia-Pacific Perspective: Redefining Obesity and its Treatment. 2000. International Obesity TaskForce, Health Communications Australia Pty Ltd; Brisbane (Australia): p. 17–18.
21. Kalantar-Zadeh K., Abott K.C., Slahudeen A.K., Kilpatrick R.D., Horwich T.B.. Survival advantages of obesity in dialysis patients.
Am J Clin Nutr 81:2005;543–554.
22. McDonald S.P., Collins J.F., Johnson D.W.. Obesity is associated with worse peritoneal dialysis outcomes in the Australia and New Zealand patient populations.
J Am Soc Nephrol 14:2003;2894–2901.
23. Zhou H., Cui L., Zhu G., Jiang Y., Gao X., Zou Y., Yang M., Liu H., Di J., Zong Y., Pan J.. Survival advantage of normal weight in peritoneal dialysis patients.
Ren Fail 33:2011;964–968.
24. Kiran V.R., Zhu T.Y., Yip T., Lui S.L., Lo W.K.. Body mass index and mortality risk in Asian peritoneal dialysis patients in Hong Kong–impact of diabetes and cardiovascular disease status.
Perit Dial Int 34:2014;390–398.
25. Kim Y.K., Kim S.H., Kim H.W., Kim Y.O., Jin D.C., Song H.C., Choi E.J., Kim Y.L., Kim Y.S., Kang S.W., Kim N.H., Yang C.W.. The association between body mass index and mortality on peritoneal dialysis: a prospective cohort study.
Perit Dial Int 34:2014;383–389.
26. Prasad N., Sinha A., Gupta A., Sharma R.K., Bhadauria D., Chandra A., Prasad K.N., Kaul A.. Effect of body mass index on outcomes of peritoneal dialysis patients in India.
Perit Dial Int 34:2014;399–408.
27. Ramkumar N., Pappas L.M., Beddhu S.. Effect of body size and body composition on survival in peritoneal dialysis patients.
Perit Dial Int 25:2005;461–469.
28. Fernandes N.M., Bastos M.G., Franco M.R., Chaoubah A., Lima Mda G., Divino-Filho J.C., Qureshi A.R.; Brazilian Peritoneal Dialysis Multicenter Study (BRAZPD) Group. Body size and longitudinal body weight changes do not increase mortality in incident peritoneal dialysis patients of the Brazilian peritoneal dialysis multicenter study.
Clinics 68:2013;51–58.
29. Choi S.J., Kim N.R., Hong S.A., Lee W.B., Park M.Y., Kim J.K., Hwang S.D., Lee H.K.. Changes in body fat mass in patients after starting peritoneal dialysis.
Perit Dial Int 31:2011;67–73.
30. Lievense H., Kalantar-Zadeh K., Lukowsky L.R., Molnar M.Z., Duong U., Nissenson A., Krishnan M., Krediet R., Mehrotra R.. Relationship of body size and initial dialysis modality on subsequent transplantation, mortality and weight gain of ESRD patients.
Nephrol Dial Transplant 27:2012;3631–3638.
31. Pellicano R., Strauss B.J., Polkinghorne K.R., Kerr P.G.. Longitudinal body composition changes due to dialysis.
Clin J Am Soc Nephrol 6:2011;1668–1675.
32. Szeto C.C., Chow K.M., Kwan B.C., Chung K.Y., Leung C.B., Li P.K.. New-onset hyperglycemia in nondiabetic Chinese patients started on peritoneal dialysis.
Am J Kidney Dis 49:2007;524–532.
33. Woodward R.S., Schnitzler M.A., Baty J., Lowell J.A., Lopez-Rocafort L., Haider S., Woodworth T.G., Brennan D.C.. Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients.
Am J Transplant 3:2003;590–598.
34. Lui S.L., Yung S., Yim A., Wong K.M., Tong K.L., Wong K.S., Li C.S., Au T.C., Lo W.K., Ho Y.W., Ng F., Tang C., Chan T.M.. A combination of biocompatible peritoneal dialysis solutions and residual renal function, peritoneal transport, and inflammation markers: a randomized clinical trial.
Am J Kidney Dis 60:2012;966–975.
35. Bernardo A.P., Oliveira J.C., Santos O., Carvalho M.J., Cabrita A., Rodrigues A.. Insulin resistance in nondiabetic peritoneal dialysis patients: associations with body composition, peritoneal transport, and peritoneal glucose absorption.
Clin J Am Soc Nephrol 10:2015;2205–2212.
36. Lo C.Y., Li L., Lo W.K., Chan M.L., So E., Tang S., Yuen M.C., Cheng I.K., Chan T.M.. Benefits of exercise training in patients on continuous ambulatory peritoneal dialysis.
Am J Kidney Dis 32:1998;1011–1018.
37. Pennell P., Rojas C., Asif A., Rossini E.. Managing metabolic complications of peritoneal dialysis.
Clin Nephrol 62:2004;35–43.